Kulicke and Soffa

Kulicke and Soffa reported Q3 FY2026. EPS came in at $1.20 against a $1.06 consensus, beat by 13.2%. Revenue was $330.4M versus $308.5M expected, beat by 7.1%. Gross margin was 47.8%, down 170 bps from last quarter.

Kulicke and Soffa Kulicke and Soffa reported a strong Q2 FY2026, with both revenue and EPS exceeding street estimates. Revenue came in at $242.6 million, a 6.1% beat over the $228.8 million estimate, while EPS of $0.79 surpassed the $0.67 estimate by 17.9%.

Kulicke and Soffa cleared a low bar, but the investable point is that the upside came with utilization and capacity language consistent with a longer general semiconductor and memory equipment recovery. The market may still be pricing this as a cyclical wire-bonder rebound, while the print points to a mix shift in which thermocompression and high-utilization ball bonding support revenue and margin at the same time.

Kulicke and Soffa beat the Street on Q4 FY2025, but the variant view is that investors are still treating the print as a cyclical assembly-equipment recovery when the call points to a higher-quality mix shift: general semiconductor utilization, NAND-led memory capacity, thermocompression, and APS all moved together. What was priced in was a modest rebound from Q3 FY2025 weakness; what surprised was the breadth of the recovery, with revenue at $177.6 million versus $169.8 million, EPS at $0.28 versus $0.22, and management guiding December revenue to $190 million with gross margins at 47%.

Kulicke and Soffa printed a headline revenue miss that looked like another false start in assembly equipment, but the variant read is that the miss concentrated in a Southeast Asia facility timing issue while the September guide preserved margin and EPS leverage. The market was likely priced for a cleaner near-term revenue recovery; what it got instead was a lower base, a specific persistence warning, and enough gross-margin discipline to keep the fiscal 2026 memory and FTC option alive.